On January 2nd, SUNSHINE PHARMA (06887) spent 2.192 million Hong Kong dollars to repurchase 49,100 shares.
Dongyang Guangyao (06887) announced that on January 2, 2026, it spent 2.192 million Hong Kong dollars to repurchase 49,100 shares.
SUNSHINE PHARMA (06887) announced on January 2, 2026 that it will spend 2.192 million Hong Kong dollars to buy back 49,100 shares.
Related Articles

Ningbo Shanshan (600884.SH) may see a change in its controlling shareholder to Wanwei Group.

Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.
Ningbo Shanshan (600884.SH) may see a change in its controlling shareholder to Wanwei Group.

Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


